<DOC>
	<DOCNO>NCT01045343</DOCNO>
	<brief_summary>The purpose clinical trial evaluate potential benefit new heart failure diagnostic system heart failure patient implanted cardiac resynchronization therapy device . This system consist patient tool , new heart failure risk score new clinician website . This study evaluate new system whole establish feasibility implement clinical practice .</brief_summary>
	<brief_title>Feasibility Study Integrated Diagnostic System Manage Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject willing able provide write informed consent Subject least 18 year age Subject willing able comply Clinical Investigation Plan Subject currently enrol Medtronic CareLink® Network Subject currently New Heart Association ( NYHA ) functional class III NYHA functional class II heart failure relate hospitalization within past 180 day Subject Medtronic Concerto®/Consulta® cardiac resynchronization therapy ( CRT ) device implant least 180 day Subject prescribed daily oral diuretic therapy management heart failure Subject enrol concurrent study exception study approve INDICATE HF Clinical Trial Leader Subject life expectancy le 1 year Subject 's CRT device estimate battery life le 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>heart failure</keyword>
	<keyword>home monitoring</keyword>
	<keyword>integrate diagnostics</keyword>
	<keyword>Cardiac Resynchronization Therapy Defibrillator ( CRT D )</keyword>
</DOC>